MEDICINES CONTROL COUNCIL
|
|
|
- Clement Webster
- 6 years ago
- Views:
Transcription
1 MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406 MERIAL SOUTH AFRICA (PTY) SANOFI-AVENTIS GASTROGARD ORELOX 200 EACH SYRINGE OMEPRAZOLE 2,28 g CEFPODOXIME PROXETIL CEFPODOXIME 200,0 mg A39/7.1.3/0580 UNICHEM SA (PTY) RENICARD 50 50,0 mg A40/21.8.2/0112 A40/21.8.2/0113 NOVARTIS SOUTH AFRICA (PTY) NOVARTIS SOUTH AFRICA (PTY) ESTALIS SEQUI PLUS 50/140 ESTALIS SEQUI PLUS 50/250 EACH PACK 4 PHASE I PATCHES EACH OESTRADIOL 4,33 mg 4 PHASE II PATCHES EACH OESTRADIOL 0,620 mg NORETHISTERONE ACETATE 2,70 mg EACH PACK 4 PHASE I PATCHES EACH OESTRADIOL 4,33 mg 4 PHASE II PATCHES EACH OESTRADIOL 0,512 mg NORETHISTERONE ACETATE 4,80 mg Notification of Jun09v2.doc July 2009 Page 1 of 7
2 A40/28/0210 AXIM PHARMACEUTICALS (PTY) ENTERO VU EACH 100,0 g POUCH BARIUM SULPHATE 81,0 g A40/18.8/0354 BAYER (PTY) YASMINELLE DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,02 mg A40/20.1.1/0368 A40/20.1.1/0369 A40/20.1.1/0370 A40/20.1.1/0371 A40/20.1.1/0372 A40/20.1.1/0373 A40/11.10/0481 A40/13.4.1/0666 A40/18.8/0693 A40/18.8/0743 RECKITT BENCKISER PHARMACEUTICALS (PTY) MERCK GENERICS RSA (PTY) PHARMA (PTY) PHARMA (PTY) BIOFLOXX 250 BIOFLOXX 500 BIOFLOXX 750 GAVISCON COOLMINT LIQUID MOMETAGEN 0,1 % ORALCON TRIGESTREL 250,0 mg 500,0 mg 750,0 mg 250,0 mg 500,0 mg 750,0 mg EACH 10,0 ml SUSPENSION SODIUM ALGINATE 500,0 mg EACH 1,0 g CREAM MOMETASONE FUROATE 1,0 mg LEVONORGESTREL 0,15 mg ETHINYL ESTRADIOL 0,03 mg EACH PACK Six light brown tablets each containing: LEVONORGESTREL 50,0 µg ETHINYL ESTRADIOL 30,0 µg Five white tablets each containing: LEVONORGESTREL 75,0 µg ETHINYL ESTRADIOL 40,0 µg Notification of Jun09v2.doc July 2009 Page 2 of 7
3 A40/18.8/0747 A40/20.2.8/0777 PHARMA (PTY) RANBAXY (S.A.) (PTY) 41/20.1.1/0043 AUROBINDO PHARMA (PTY) 41/20.1.1/0044 AUROBINDO PHARMA (PTY) 41/25.2/0060 FRESENIUS KABI SOUTH AFRICA (PTY) 41/20.2.2/0107 GULF DRUG COMPANY (PTY) 41/20.2.2/0124 GULF DRUG COMPANY (PTY) 41/11.3/0153 BOUWER BARTLETT (PTY) 41/7.1.3/0175 BOUWER BARTLETT (PTY) 41/11.3/0180 BOUWER BARTLETT (PTY) 41/20.2.2/0240 GULF DRUG COMPANY (PTY) 41/20.2.8/0248 AUROBINDO PHARMA (PTY) 41/21.1/0362 SANOFI-SYNTHELABO (PTY) 41/21.1/0363 SANOFI-SYNTHELABO (PTY) HY-AN SONKE-ABACAVIR 300 AUROPROZIL 250 mg AUROPROZIL 500 mg SMOFlipid 20 % GULF FLUCONAZOLE 200 GULF FLUCONAZOLE 150 GLENMARK CAPSULES 15 mg GLENMARK PERINDOPRIL TABLETS 4 mg GLENMARK CAPSULES 10 mg GULF FLUCONAZOLE 50 AURO ABACAVIR TABLETS 300 mg INSULIN GLARGINE WINTHROP INSULIN GLARGINE SANOFI-AVENTIS Ten yellow tablets each containing: LEVONORGESTREL 125,0 µg ETHINYL ESTRADIOL 30,0 µg Seven inert tablets LEVONORGESTREL 0,03 mg ABACAVIR SULPHATE ABACAVIR 300,0 mg CEFPROZIL MONOHYDRATE CEFPROZIL 250,0 mg CEFPROZIL MONOHYDRATE CEFPROZIL 500,0 mg EACH 1 000,0 ml SUSPENSION SOY OIL 60,0 g OLIVE OIL 50,0 g FISH OIL 30,0 g MEDIUM CHAIN TRIGLYCERIDES 60,0 g EACH CAPSULE FLUCONAZOLE 200,0 mg EACH CAPSULE FLUCONAZOLE 150,0 mg EACH CAPSULE MONOHYDRATE 15,0 mg PERINDOPRIL TERT- BUTYLAMINE 4,0 mg EACH CAPSULE MONOHYDRATE 10,0 mg EACH CAPSULE FLUCONAZOLE 50,0 mg ABACAVIR SULPHATE ABACAVIR 300,0 mg INSULIN GLARGINE 3,64 mg INSULIN GLARGINE 3,64 mg Notification of Jun09v2.doc July 2009 Page 3 of 7
4 41/20.2.8/0386 AUROBINDO PHARMA (PTY) 41/5.7.2/0397 CIPLA MEDPRO (PTY) 41/5.7.2/0398 CIPLA MEDPRO (PTY) 41/5.7.2/0399 CIPLA LIFE SCIENCES (PTY) 41/5.7.2/0400 CIPLA LIFE SCIENCES (PTY) 41/8.4/0602 ADCOCK INGRAM 41/8.4/0603 ADCOCK INGRAM 41/2.5/0705 PHARMA (PTY) 41/2.5/0706 PHARMA (PTY) 41/2.5/0707 PHARMA (PTY) 41/2.5/0708 PHARMA (PTY) AURO ABACAVIR ORAL SOLUTION 20 mg/ml GRANICIP 1 mg GRANICIP 2 mg CIPLA 1 mg CIPLA 2 mg VITAHES VITAFUSAL LAMOTRIGINE 25 LAMOTRIGINE 50 LAMOTRIGINE 100 LAMOTRIGINE 200 ABACAVIR SULPHATE ABACAVIR 20,0 mg 1,0 mg 2,0 mg 1,0 mg 2,0 mg EACH 1 000,0 ml SOLUTION HYDROXYETHYL STARCH 130/0,42 60,0 g SODIUM CHLORIDE 9,0 g EACH 1 000,0 ml SOLUTION HYDROXYETHYL STARCH 130/0,42 60,0 g SODIUM CHLORIDE 6,0 g POTASSIUM CHLORIDE 0,4 g CALCIUM CHLORIDE DIHYDRATE 0,134 g MAGNESIUM CHLORIDE HEXAHYDRATE 0,2 g SODIUM ACETATE TRIHYDRATE 3,7 g LAMOTRIGINE 25,0 mg LAMOTRIGINE 50,0 mg LAMOTRIGINE 100,0 mg LAMOTRIGINE 200,0 mg 41/20.1.1/0721 PHARMACARE LIMITED ZEFURIME 250 mg CEFUROXIME AXETIL CEFUROXIME 250,0 mg Notification of Jun09v2.doc July 2009 Page 4 of 7
5 41/20.1.1/0722 PHARMACARE LIMITED ZEFURIME 500 mg CEFUROXIME AXETIL CEFUROXIME 500,0 mg 41/21.8.2/0842 BAYER (PTY) YAZ DROSPIRENONE 3,0 mg ETHINYLESTRADIOL 0,02 mg 41/21.5.1/0968 GLAXOSMITHKLINE AVAMYS EACH SPRAY FLUTICASONE FUROATE 27,5 µg 41/7.1.3/1070 SPECPHARM (PTY) NATRAZONE 25 25,0 mg 41/7.1.3/1071 SPECPHARM (PTY) NATRAZONE 50 50,0 mg 41/7.1.3/1072 SPECPHARM (PTY) NATRAZONE ,0 mg 41/7.1.3/1073 SPECPHARM (PTY) NATRAZONE 12,5 12,5 mg 41/5.7.2/1079 ADCOCK INGRAM 41/5.7.2/1080 ADCOCK INGRAM 42/20.1.1/0204 AUROBINDO PHARMA (PTY) 42/20.1.1/0205 AUROBINDO PHARMA (PTY) ADCO 1 mg/1 ml ADCO 3 mg/3 ml AURO CEFALEXIN TABLETS 250 mg AURO CEFALEXIN TABLETS 750 mg 42/20.1.1/0509 PHARMACARE LIMITED ASPEN 250 mg 42/20.1.1/0510 PHARMACARE LIMITED ASPEN 500 mg 42/26/0528 PHARMACARE LIMITED ASPEN 10 mg/5 ml 1,0 mg EACH 3,0 ml SOLUTION 3,0 mg CEFALEXIN MONOHYDRATE CEFALEXIN 250,0 mg CEFALEXIN MONOHYDRATE CEFALEXIN 750,0 mg HEMIHYDRATE EQUIVALENT TO 250,0 mg HEMIHYDRATE EQUIVALENT TO 500,0 mg EACH 5,0 ml SOLUTION 10,0 mg Notification of Jun09v2.doc July 2009 Page 5 of 7
6 42/26/0529 PHARMACARE LIMITED ASPEN 20 mg/10 ml 42/26/0530 PHARMACARE LIMITED ASPEN 50 mg/25 ml 42/26/0531 PHARMACARE LIMITED ASPEN 100 mg/50 ml 42/26/0532 PHARMACARE LIMITED ASPEN 200 mg/100 ml 42/20.1.1/0601 AUROBINDO PHARMA (PTY) 42/20.1.1/0602 AUROBINDO PHARMA (PTY) 42/20.1.1/0603 AUROBINDO PHARMA (PTY) 42/20.1.1/0604 AUROBINDO PHARMA (PTY) 42/11.3/0628 RANBAXY (S.A.) (PTY) 42/11.3/0629 RANBAXY (S.A.) (PTY) 42/21.2/0702 ARROW PHARMA 42/21.2/0703 ARROW PHARMA 42/21.2/0704 ARROW PHARMA 42/21.2/0705 ARROW PHARMA 250 mg 500 mg mg mg RAN 10 RAN 15 AROGLIM 1 mg AROGLIM 2 mg AROGLIM 3 mg AROGLIM 4 mg EACH 10,0 ml SOLUTION 20,0 mg EACH 25,0 ml SOLUTION 50,0 mg EACH 50,0 ml SOLUTION 100,0 mg EACH 100,0 ml SOLUTION 200,0 mg EACH VIAL CEFOTAXIME 250,0 mg EACH VIAL CEFOTAXIME 500,0 mg EACH VIAL CEFOTAXIME 1 000,0 mg EACH VIAL CEFOTAXIME 2 000,0 mg EACH CAPSULE MONOHYDRATE 10,0 mg EACH CAPSULE MONOHYDRATE 15,0 mg GLIMEPIRIDE 1,0 mg GLIMEPIRIDE 2,0 mg GLIMEPIRIDE 3,0 mg GLIMEPIRIDE 4,0 mg Notification of Jun09v2.doc July 2009 Page 6 of 7
7 42/21.2/0706 ARROW PHARMA 42/21.2/0707 ARROW PHARMA 42/21.2/0708 ARROW PHARMA 42/21.2/0709 ARROW PHARMA 42/1.2/0718 ARROW PHARMA 42/1.2/0719 ARROW PHARMA 44/26/0024 ACCORD HEALTHCARE (PTY) 44/26/0025 ACCORD HEALTHCARE (PTY) 1 mg 2 mg 3 mg 4 mg ARROW CITALOPRAM 40 mg ARROW CITALOPRAM 20 mg IRINOTAS 100 ACCORD IRINOTECAN 100 GLIMEPIRIDE 1,0 mg GLIMEPIRIDE 2,0 mg GLIMEPIRIDE 3,0 mg GLIMEPIRIDE 4,0 mg CITALOPRAM HYDROBROMIDE CITALOPRAM 40,0 mg CITALOPRAM HYDROBROMIDE CITALOPRAM 20,0 mg EACH 5,0 ml VIAL IRINOTECAN 100,0 mg EACH 5,0 ml VIAL IRINOTECAN 100,0 mg MS MANDISA HELA REGISTRAR OF MEDICINES Notification of Jun09v2.doc July 2009 Page 7 of 7
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/7.5/0281 PHARMACARE LIMITED
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/5.1/09 INGELHEIM 08/5.1/10
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 30/2.10/0392 TEVA TEVA BACLOFEN
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 47/26/0920 SANOFI-AVENTIS
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 06/17.1.6/07 AFRIVET LOGISTICS
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 July 2011 No. 4761
GOVERNMENT GAZETTE OF THE REPUBLIC OF N$4.00 WINDHOEK - 26 July 2011 No. 4761 CONTENTS Page GOVERNMENT NOTICE No. 122 Registration of certain medicines: Medicines and Related Substances Control Act, 2003...
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
Medicines availability short-term supply issues Last updated 01/05/18
Short-term supply issues This resource includes availability information on medicines that are reported to have supply issues, with next expected availability within the next three months. This list is
PRODUCT LIST GENERAL - TABLETS
SR. NO. PRODUCT LIST GENERAL - TABLETS 1 Ciprofloxacin Tablets IP 500 mg 2 Ciprofloxacin And Tinidazole Tablets 3 Cefpodoxime Proxetil Tablets IP 4 Cefixime Dispersible Tablets 200 mg 5 Cefixime Dispersible
COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH
1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder
500 Tablet 10,s Rs do- Each Tablet contains:- Levofloxacin as
Product List S.No# Reg.No Name of Drug(s)& composition Packing M R P Tablet Section Approved Shelf Life 1 072298 Wevofloxin-250 Tablet 10,s Rs.250.00 Two Years Levofloxacin as Hemihydrate 250mg (Manufacturer'
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$2.00 WINDHOEK - 3 June 2011 No. 4726
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$2.00 WINDHOEK - 3 June 2011 No. 4726 CONTENTS Page GOVERNMENT NOTICE No. 71 Medicines and Related Substances Control Act, 2003: Registration of certain medicines...
Akums Drugs and Pharmaceuticals Ltd. Plant-1, Quality Control Laboratory, , Sector-6A, I.I.E., SIDCUL, Ranipur, Haridwar
Last Amended on - Page 1 of 5 I. DRUGS & PHARMACEUTICALS A. General Tests of Biological Testing for Pharmaceutical Dosage Forms 1. Pharmaceutical Dosage Like Tablet,, Dry Syrup and Oral Suspension Total
Hormone Products for Postmenopausal Use in the United States and Canada
Hormone Products for Postmenopausal Use in the United States and Canada Copyright The North American Menopause Society October 25, 2011 Table 1. Oral ET products for postmenopausal use in the United States
TennCare Program TN MAC Price Change List As of: 03/30/2017
1 TN List Run : 03/30/17 Old PRAZOSIN HCL 5 MG CAPSULE ORAL 03/29/2017 1.11209 1.12560 ( 1.2) CAPTOPRIL 12.5 MG TABLET ORAL 07/07/2015 1.07191 1.10416 ( 2.9) ISOSORBIDE DINITRATE 5 MG TABLET ORAL 03/29/2017
ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS
SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 26 February 2013 No. 5142
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$4.00 WINDHOEK - 26 February 2013 No. 5142 CONTENTS Page GOVERNMENT NOTICES No. 30 Notification of registration of certain medicines: Medicines and Related
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$5.60 WINDHOEK - 31 July 2012 No. 5003
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$5.60 WINDHOEK - 31 July 2012 No. 5003 CONTENTS Page GOVERNMENT NOTICES No. 186 Cancellation of certain medicines: Medicines and Related Substances Control
Alvizia Healthcare Private Limited
+91-8048413356 Alvizia Healthcare Private Limited https://www.alviziahealthcare.net/ We are one of the leading manufacturers, wholesaler and traders of the Pharmaceutical Products. Owing to their rich
Advance Notification of Amendments to the March 2017 Drug Tariff
Advance Notification of Amendments to the March 2017 Drug Tariff ADDITIONS Part I - Drugs And Preparations Special Container Drug Qty Price Acetylcysteine 600mg capsules 30 39.95 A Caffeine citrate 50mg/5ml
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
Tablets, Capsules, Syrup, Dry syrup, Suspensions, Lotions and food products.
Renewed Life sciences - A WHO-GMP Complaint plant situated in pollution free atmosphere and lush green environment of Haridwar, Uttrakhand, Incorporated to pursue an ambitious goal of producing specialized
Multi-Vitamin PART OF YOUR ESSENTIALS PACK
Supplement Details Multi-Vitamin PART OF YOUR ESSENTIALS PACK A perfectly balanced all rounder. Our high quality multivitamin gives you a well balanced daily dose of a plethora of essential vitamins and
OLFEMY CARE (DIVISION OF VENTUS PHARMACEUTICAL PVT LTD) (ISO 9001: 2008 CERTIFIED COMPANY)
OLFEMY CARE (DIVISION OF VENTUS PHARMACEUTICAL PVT LTD) (ISO 9001: 2008 CERTIFIED COMPANY) SCF-320 GROUND FLOOR AND BASEMENT MM- MANIMAJRA, CHANDIGARH-160101, CONTACT NO:9216504338, 9915757530 E-MAIL US
Product List Finished Dosage Forms (FDF) B2B Business
Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium
PROFESSIONAL INFORMATION
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled: Complementary Medicine PROPRIETARY NAME AND DOSAGE FORM: BEROCCA
Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition
Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists
+91-8071678267 Biovaxia Pharma http://www.biovaxia.com/ We are engaged in the specified business of manufacturer, supplier, trader & exporter of Pharmaceutical Tablet and Injections. Offered medicinal
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 31 October 2014
31 October 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and
AETNA BETTER HEALTH January 2017 Formulary Change(s)
AETNA BETTER HEALTH January 2017 Formulary Change(s) The following updates will be made to the Aetna Better Health of MI formulary on March 1, 2017 Drug Name, Strength, Dosage Form ALFUZOSIN HCL ER 10
Legal Supplement Part B Vol. 57, No. 6 18th January, NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS
Legal Supplement Part B Vol. 57, No. 6 18th January, 2018 11 LEGAL NOTICE NO. 5 REPUBLIC OF TRINIDAD AND TOBAGO FOOD AND DRUGS ACT, CHAP. 30:01 NOTIFICATION NOTICE OF APPROVAL IN RESPECT OF NEW DRUGS ISSUED
Latest Gazetted Regulations and Guidelines : SMASA Concerns/Comments
THE SELF MEDICATION MANUFACTURERS ASSOCIATION OF SOUTH AFRICA (SMASA) Latest Gazetted Regulations and Guidelines : SMASA Concerns/Comments Dr Deepa Maharaj Chair Technical & Regulatory Committee SAPRAA
NIT 97 - APPROVED DRUG LIST
1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin
Advance Notification of Amendments to the June 2018 Drug Tariff
Advance Notification of Amendments to the June 2018 Drug Tariff ADDITIONS Zero Discount Tacrolimus 1mg modified-release capsules Part I - Drugs And Preparations Special Container * This pack only (others
Packing List SS#: From: HEALTH PARTNERS INTERNATIONAL 2907 PORTLAND DRIVE OAKVILLE ON CANADA L6H 5S4. Ship to: Carrier:
30 907 PORTLAND DRIVE OAKVILLE ON CANADA LH S4 PHONE:(90) 70-990 X FAX:(90) 70-74 ShipDate: /9/ Shipper# PTP30- Bott/0ml 0 TUBE/7G Tube/30g Box/ Box/ Kaopectate OS 70mg/mL, Bottle/0mL 790043 Attapulgite
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Health Drug Plan and Extended Benefits Branch April 2008 Bulletin #114 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN UPDATE TO THE 57th EDITION OF THE SASKATCHEWAN FORMULARY The
Copenhagen, Denmark September 2014
Joint UNICEF, UNFPA & WHO meeting with manufacturers and suppliers of diagnostic products, vaccines, finished pharmaceutical products and active pharmaceutical ingredients 1 Priorities for Product Development
NIT165 - RECEIVED PRICE DETAIL. Quantity in Unit/SKU. Company Name. Abbott Healthcare Private Ltd.
S C I Total 1 120003 Acenocoumarol/Nicoumalone Tablet 2 mg 10 x 10 15,000 223.33 6 6 26.7996 250.1296 2 120016 Amitriptyle Tab. IP - 25 mg 10X10 4,120 Micron Pharmaceuticals 27.9 12 3.348 31.248 3 120030
CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs
page 1 CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs 2011 The following categories are included in this work programme: 1. Medicines
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA. N$4.00 WINDHOEK - 14 August 2013 No. 5263
GOVERNMENT GAZETTE OF THE REPUBLIC OF NAMIBIA N$4.00 WINDHOEK - 14 August 2013 No. 5263 CONTENTS Page GOVERNMENT NOTICES No. 211 No. 212 Request for submission of name of pharmacist for nomination for
PRODUCT LIST. Basic Solutions. Multiple Electrolyte Solutions. Plasma Volume Expanders. Premix Solutions. Irrigation Solutions
PRODUCT LIST Basic Solutions Multiple Electrolyte Solutions Plasma Volume Expanders Premix Solutions Irrigation Solutions Since established in 198, POLIFARMA has continued I.V. Solution production process
AVAILABLE DOSSIERS. Product name Pharmaceutical form Strength Reference Therapeutic class
DOSSIER LIST AVAILABLE DOSSIERS Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM Esomeprazole sodium Omeprazole sodium injection / 40 mg Nexium / AstraZeneca
UPLB-S , SUPPLY AND DELIVERY OF DRUGS AND MEDICINES TECHNICAL SPECIFICATION FOR THE PUBLIC BIDDING OF: OPENING OF BIDS:
1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic bottle 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic Bottle 3 0.9 Sodium Chloride with 5% Dextrose 1000 ml in plastic bottle
PBS PRICE INCREASES - AUGUST 2014 SCHEDULE
Price increase review - general PBS benzylpenicillin 600 mg injection, 1 x 600 mg vial 1775K, 3398W, BenPen 3.84 4.38 3486L benzylpenicillin 3 g injection, 1 x 3 g vial 2647H, 3399X, BenPen 6.60 7.55 3487M
GUIDELINE ON THE CATEGORISATION OF EXTENSION APPLICATIONS (EA) versus VARIATIONS APPLICATIONS (V) OCTOBER 2003
EUROPN COMMISSION ENTERPRISE DIRECTORATE-GENERAL Single market, implementation and legislation for consumer goods Pharmaceuticals : regulary framework and market authorisations Brussels, F2/AW D(2002)
PROFESSIONAL INFORMATION
This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use. SCHEDULING STATUS: Unscheduled (Complementary medicine) PROPRIETARY NAME AND DOSAGE FORM: BEROCCA
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 28 February 2014
28 February 2014 TENDER RESULTS PHARMAC has resolved to award tenders for for Sole Subsidised Supply Status and Status for some products included in the Invitation to Tender, dated 07 November 2013. Some
Palliative Coverage Drug Benefit Supplement
Palliative Coverage Drug Benefit Supplement Effective April 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
Information for Vermont Prescribers of Prescription Drugs Long Form
Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale
PRODUCTS ARE MANUFACTURED BY WHO GMP CERTIFIED PLANTS. PRODUCTS ARE APPROVED BY D.C.G.I.
OLENS HEALTH CARE PVT. LTD SHOP NO: 20, 2 nd FLOOR, OLD ROPAR ROAD NEAR SAMADHI GATE, MOTOR MARKET MANIMAJRA, CHANDIGARH-160101, CONTACT NO: +919466093266, +918558992442 E-MAIL: olens.healthcare@gmail.com
https://www.indiamart.com/cureworld-pharmaceutical/
+91-8071677510 Cure World Pharmaceutical https://www.indiamart.com/cureworld-pharmaceutical/ We are one of the leading Manufacturer and Trader of an excellent quality Pharmaceutical Tablet, Pharmaceutical
STAATSKOERANT, 13 JULIE 2007 No KENNISGEWING 826 VAN 2007 MEDISYNEBEHEERRAAD VOORWAARDES VIR DIE REGISTRASIE VAN 'N MEDISYNE IN TERME VAN DIE
2 NO.30047 GOVERNMENT GAZETTE, 13 JULY 2007 No. CONTENTS Page No. Gazette No. No. INHOUD Bladsy No. Koerant No. Health, Department of General Notice GENERAL NOTICE 826 Medicines and Related Substances
Iraq NDI Iraq 04-J India 05-AH France Famar Lyon France 05-D UNITED ARAB EMIRATES. Iraqi Biocon Limited Indian 06-AA0-001
nam origmanufacturer nammanufacturer National code Mousel Scientific Iraq NDI Iraq 04-J00-042 Sandoz GmbH Austria for Sandoz GmbH by Sandoz Ilac Sanayi ve India 05-AH0-040 France Famar Lyon France 05-D00-024
Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity
Supporting information Volume 72 (2016) Supporting information for article: Comparative analysis of anti-polyglutamine Fab crystals grown on Earth and in microgravity Gwen E. Owens, Danielle M. New, Alejandra
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes. 30 April 2014
30 April 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Status for some products included in the 2012/13 Invitation to Tender, dated 31 October 2012 and
All Pharmacy and Prescribing Providers. Subject: State Maximum Allowable Cost (MAC) Updates
INDIANA HEALTH COVERAGE PROGRAMS P R O V I D E R B U L L E T I N B T 2 0 0 7 1 2 M A Y 2 9, 2 0 0 7 To: All Pharmacy and Prescribing Providers Subject: State Maximum Allowable Cost (MAC) Updates Effective
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Teneligliptin Hydrobromide + Metformin HCL (SR) Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of s National Pricing Authority ORDER New
6 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu
PRODUCT MANUFACTURING LIST Tablet SECTIONS :- S.No. Composition Claim Pack Size Packing Type Remarks 1 Each Film coated Tablet Contains :- Ofloxacin 200 mg 10 x 10 Alu 2 Each Film coated Tablet Contains
Recommended comparator products: Medicines for HIV/AIDS and related diseases
Recommended comparator products: Medicines for HIV/AIDS and related diseases Comparator products should be purchased from a well regulated market with stringent regulatory authority 1. Invited medicinal
DOSSIER LIST. tlo_seledyn.pdf :38:01 CMY K CM MY CY
tlo_seledyn.pdf 1 22.08.2017 14:38:01 C M Y CM MY CY CMY K DOSSIER LIST tlo_seledyn.pdf 1 22.08.2017 14:38:01 PRODUCT NAME PHARMACEUTICAL FORM STRENGTH REFERENCE THERAPEUTIC CLASS ALIMENTARY TRACT & METABOLISM
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs CADUET (amlodipine besylate/atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have
Advance Notification of Amendments to the December 2018 Drug Tariff
Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen
Electronic Prescription Service (EPS) dm+d and Prescribing Systems
Electronic Prescription Service (EPS) dm+d and Prescribing Systems dm+d and Prescribing Systems The NHS Dictionary of Medicines and Devices (dm+d) is the standard for transferring medicine and medical
We are counted among foremost manufacturers, suppliers and exporters of inorganic chemicals and Pharma bulk drugs. To suit various industrial
We are counted among foremost manufacturers, suppliers and exporters of inorganic chemicals and Pharma bulk drugs. To suit various industrial purposes, we avail our entire assortment in IP,BP,USP, GR,
Updates to the Alberta Drug Benefit List. Effective February 1, 2018
Updates to the Alberta Drug Benefit List Effective February 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)
NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order,
What s New 12.06.2018 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations under Drugs (Prices Control) Order, 2013 NPPA has fixed/revised ceiling prices/retail prices of 22 formulations
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
Revisions to USP 31 NF 26, Second Supplement
Revisions to USP 31 NF 26, Second Supplement (published May 2008) Published April 2008 General Chapters Monographs:A C D N O S T Z Monograph Section Head Scientific Liaison DANTROLENE SODIUM CAPSULES PF
Anti Infectives. Product Generic Name Dosage Form Strength Available Pack Sizes. Powder for Oral Suspension
Product Disclaimer Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk. Product
MemGold TM. MD1-39 is presented as 96 x 10 ml conditions.
MemGold TM MD1-39 MemGold* is based on crystallization conditions data mined from the Protein Data Bank and is a rationalized sparse matrix screen containing 96 conditions covering a range of ph, PEGs
TENDER RESULTS. Notification of Product Changes (NOPC) forms and Pharmacodes
30 June 2014 TENDER RESULTS PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2012/13 Invitation to Tender, dated 31 October
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube
Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube On Aug. 24, 2015, Allergan recalled three lots (86258 expires September 2017, 87189 December 2017 and 87514 February
This indication includes the temporary relief of burning, irritation, and/or discomfort due to dryness of the eye.
Page 1 of 5 SCHEDULING STATUS Schedule 0 PROPRIETARY NAME AND DOSAGE FORM REFRESH LIQUIGEL COMPOSITION REFRESH LIQUIGEL lubricant eye drops contain carboxymethylcellulose sodium 10 mg/ml. Preservative:
What s New
What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related
Advance Notification of Amendments to the August 2018 Drug Tariff
Advance Notification of Amendments to the August 2018 Drug Tariff ADDITIONS Zero Discount Brivaracetam 100mg tablets Brivaracetam 25mg tablets Brivaracetam 50mg tablets Brivaracetam 75mg tablets Maraviroc
CONTACT POLPHARMA GROUP POLPHARMA B2B
DOSSIER FDFLIST Product name Pharmaceutical form Strength Reference Therapeutic class ALIMENTARY TRACT & METABOLISM 1. Esomeprazole sodium or injection 40 mg Nexium / AstraZeneca Antiulcerant 2. Omeprazole
Administration and Supply of Emergency Medicines
APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule
Upper Peninsula Health Plan Advantage (HMO) (List of Covered Drugs)
Analgesics Opioid Analgesics, Long-acting fentanyl 100 mcg/hr patch td72 morphine sulfate 30 mg tablet er Opioid Analgesics, Short-acting fentanyl citrate 200 mcg lozenge hd hydrocodone/acetaminophen 5
PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014
PRESCRIPTION SAVINGS CLUB FLAT- PRICED GENERIC DRUG LIST (EMDEON) Effective August 20, 2014 The Prescription Savings Club provides its members with significant savings on prescription medications. The
Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA
![Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA](/thumbs/85/92881277.jpg "Pharmacopeial Forum 818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA")
818 INTERIM REVISION ANNOUNCEMENT Vol. 35(4) [July Aug. 2009] ERRATA Following is a list of errata and corrections to USP NF. The page number indicates where the item is found and in which official or
DATE OF PRE-BID CONFERENCE: DEADLINE OF SUBMISSION OF BIDS: OPENING OF BIDS:
UHS FC: 8703417 Dr. Marilyn Reaño 1 1 0.3 Sodium Chloride with 5% Dextrose in 1000 ml in plastic 120 btl 70.00 8,400.00 2 0.3 Sodium Chloride With 5% Dextrose In 500 ml In Plastic 240 btl 70.00 16,800.00
Release of the 2014/15 Invitation to Tender
6 November 2014 Release of the 2014/15 Invitation to Tender The 2014/15 Invitation to Tender (2014/15 ITT) has been distributed today. Please note that the Electronic Portal will not be available until
List of Liquid Oral/Dry Syrup Section
List of Liquid Oral/Dry Syrup Section Antibiotics & Anti-Infective S.No Product Name Composition 1. Amoxicillin Oral Suspension BP ( /5ml ) ( Zeemox Syrup ) 2. Amoxicillin Oral Suspension BP (/5ml ) 3.
MANUFACTURING PROBLEMS AS OF 29th February 2016
MANUFACTURING PROBLEMS AS OF 29th February 2016 Drug Manufacturer Brand Name Comments Amoxycillin powder for Injection 1gram x 10 Amoxycillin powder for Injection 500mg x 10 Amoxycillin & Clavulanic 600mg
Determination that DEMEROL (Meperidine Hydrochloride) Injectable and Other Drug
This document is scheduled to be published in the Federal Register on 04/28/2017 and available online at https://federalregister.gov/d/2017-08582, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
Summary of Changes to the Alberta Drug Benefit List
Summary of Changes to the Alberta Drug Benefit List Effective April 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number:
Revisions to USP 30 NF 25, Second Supplement
Revisions to USP 30 NF 25, Second Supplement Published June 2007 General Chapters Monographs: A C D N O S T Z Monograph Monograph Section Scientific Liaison USP Reference standards Dissolution, Procedure